Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

FDA approves Otiprio for pediatric patients undergoing tympanostomy tube placement

Dec. 14, 2015

Otonomy begins enrollment in phase III trial of OTO-104 in Meniere's disease

Nov. 20, 2015

Otonomy initiates clinical development of OTO-311 for tinnitus

Nov. 17, 2015

OticPharma licenses rights to Otodyne's otitis media program

Nov. 6, 2015

Hearing loss reduction with SENS-90 in severe noise model leads to clinical development

Oct. 28, 2015

Auris Medical and King's College London to collaborate on small-molecule tinnitus therapy

Oct. 27, 2015

New company Decibel Therapeutics launched to address hearing loss

Oct. 19, 2015

Otonomy receives IND application clearance for tinnitus candidate OTO-311

Oct. 7, 2015

Otologic licenses sensory hair cell regeneration technology from Hough Ear Institute

Oct. 2, 2015

Biophysical mechanisms causing susceptibility to tinnitus identified

Sep. 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...